Recent Antiplatelet Drug Trials in the Acute Coronary Syndromes: Clinical Interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT

Author： Alexander J.H.   Harrington R.A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.56, Iss.6, 1998-12, pp. : 965-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ongoing clinical trials of anti-platelet agents in the management of acute ischaemic coronary syndromes

By Straznicky I.T.   Zambanini A.   White H.D.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 811-822

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Menozzi Alberto   Lina Daniela   Conte Giulio   Mantovani Francesco   Ardissino Diego  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 27-42

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Natarajan Arun   Tarique Ahmar   Zaman Azfar G  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 388-391

Royal College Of Physicians

Access to resources Recommend Favorite

Triple Antiplatelet Therapy in Acute Coronary Syndromes

By Valgimigli Marco   Minarelli Monica  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1703-1719

Adis International

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A   Mazzola Jennifer L   Przylenk Karin  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite